- Confirmation of the intention to launch in Q4 2026 the €500 million capital increase with Preferential Subscription Rights (“PSRs”) announced in February 2026
- A necessary transaction to restore the Group’s financial position, strengthen its equity base, maintain compliance with its bank covenants and continue executing its strategy. Eramet is also pursuing the other two pillars of its funding plan: performance improvement (in particular through ReSolution), and asset monetization.
- Agreement reached between the two reference shareholders on the terms of their participation in the rights issue
- Strategic decision by the French State to increase its stake in Eramet through a strategic investment by the Agence des Participations de l’Etat (“APE”), in line with its objectives to secure critical metals. Accordingly, as part of the transaction:
- The APE will subscribe for its pro-rata share (27.1% of the share capital) and purchase, depending on the transaction reference price, all or part of Sorame-CEIR’s PSRs so that APE’s effective voting rights[i] at a General Meeting do not exceed 49%;
- Should the APE not purchase all of Sorame-CEIR’s PSRs, Sorame-CEIR would then subscribe to the balance of the PSRs it received; Sorame-CEIR would subsequently have the right to exercise a put option, while the APE would have the right to exercise a call option, over the new shares subscribed for by Sorame-CEIR in the rights issue.
- The Company’s other shareholders, in particular the free-float, will be able to participate in the rights issue by exercising their PSRs during the subscription period[ii]. Those who do not wish to participate may sell their PSRs on the market, notably allowing existing shareholders or new investors to acquire them and participate in the rights issue[iii].
- Following its investment, the APE will become the Group’s largest shareholder, confirming Eramet’s strategic importance to French and European sovereignty in critical metals. Sorame-CEIR will become the second-largest shareholder.
[i] Effective voting rights: voting rights exercisable at a General Meeting, calculated on the basis of the average quorum across the 2024 to 2026 General Meetings
[ii] For retail shareholders, as the transaction is an offer to the public open in France, eligibility to participate must be assessed on a case-by-case basis, depending on their country of residence and in accordance with applicable securities laws and regulations
[iii] Subject to applicable securities regulations outside France








